Characteristics of United States Counties in Which Heart Failure Clinical Trials of Pharmacotherapy Were Conducted

被引：2
|
作者：
Cox, Elisabeth [1 ]
Alsalloum, Muath A. [1 ,2 ]
Vander Schaaf, Marin [1 ]
Alfehaid, Abdulaziz S. [1 ,3 ]
Alnewais, Marwah E. [1 ,4 ]
Weeda, Erin R. [1 ,5 ]
机构：
[1] Med Univ South Carolina, Coll Pharm, Charleston, SC USA
[2] Imam Abdulrahman Bin Faisal Univ, Coll Clin Pharm, Dept Pharm Practice, Dammam, Saudi Arabia
[3] King Faisal Gen Hosp, Pharmaceut Care Serv, Alahsa Hlth Cluster, Minist Hlth, Al Hufuf, Saudi Arabia
[4] King Faisal Univ, Coll Clin Pharm, Alahsa, Saudi Arabia
[5] Med Univ South Carolina, Dept Clin Pharm & Outcomes Sci, 280 Calhoun St,QE213C MSC140, Charleston, SC 29425 USA
来源：
CIRCULATION-HEART FAILURE | 2023年 / 16卷 / 07期
关键词：
applicability; clinical trials; diversity; external validity; generalizable; rural; social determinants of health;
D O I：
10.1161/CIRCHEARTFAILURE.122.010449
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Community Socioeconomic Distress is Associated With Poor Access to Heart Failure Clinical Trials in the United States
    Chandrabhatla, Anirudha S.
    Horgan, Taylor M.
    Narahari, Adishesh K.
    Yount, Kenan W.
    Teman, Nicholas R.
    Kern, John A.
    Mazimba, Sula
    Bergin, James D.
    Yarboro, Leora
    CIRCULATION, 2023, 148
  • [2] Conduct of Clinical Trials in Acute Heart Failure: Regional Differences in Heart Failure Clinical Trials
    Fiuzat, Mona
    Califf, Robert M.
    HEART FAILURE CLINICS, 2011, 7 (04) : 539 - +
  • [3] Racial and Ethnic Diversity in SARS-CoV-2 Vaccine Clinical Trials Conducted in the United States
    Khalil, Lana
    Leary, Maranda
    Rouphael, Nadine
    Ofotokun, Ighovwerha
    Rebolledo, Paulina A.
    Wiley, Zanthia
    VACCINES, 2022, 10 (02)
  • [4] The representation of females in clinical trials for substance use disorder conducted in the United States (2010-19)
    Gunn, Christine M.
    Pankowska, Magda
    Harris, Miriam
    Helsing, Emma
    Battaglia, Tracy A.
    Bagley, Sarah M.
    ADDICTION, 2022, 117 (10) : 2583 - 2590
  • [5] Rethinking heart failure clinical trials: the heart failure collaboratory
    Alkalbani, Mutaz
    Psotka, Mitchell A.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [6] Clinical trials of carvedilol in heart failure
    Tang W.H.W.
    Fowler M.B.
    Heart Failure Reviews, 1999, 4 (1) : 79 - 88
  • [7] The Impact of Worsening Heart Failure in the United States
    Cooper, Lauren B.
    DeVore, Adam D.
    Felker, G. Michael
    HEART FAILURE CLINICS, 2015, 11 (04) : 603 - +
  • [8] Improving Heart Failure Therapeutics Development in the United States The Heart Failure Collaboratory
    O'Connor, Christopher M.
    Psotka, Mitchell A.
    Fiuzat, Mona
    Lindenfeld, Joann
    Abraham, William T.
    Bristow, Michael R.
    Canos, Daniel
    Harrington, Robert A.
    Hillebrenner, Matt
    Jessup, Mariell
    Malik, Fady I.
    Solomon, Scott D.
    Stockbridge, Norman
    Tcheng, James E.
    Unger, Ellis F.
    Whellan, David J.
    Zuckerman, Bram
    Califf, Robert M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (04) : 443 - 453
  • [9] Demographic diversity of participants in Pfizer sponsored clinical trials in the United States
    Rottas, Melinda
    Thadeio, Peter
    Simons, Rachel
    Houck, Raven
    Gruben, David
    Keller, David
    Scholfield, David
    Soma, Koshika
    Corrigan, Brian
    Schettino, Annette
    McCann III, Patrick J.
    Hellio, Marie -Pierre
    Natarajan, Kannan
    Goodwin, Rob
    Sewards, Judy
    Honig, Peter
    MacKenzie, Rod
    CONTEMPORARY CLINICAL TRIALS, 2021, 106
  • [10] Selection of endpoints for heart failure clinical trials
    Zanolla, L
    Zardini, P
    EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (06) : 717 - 723
12345